Systematic review with meta-analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low-risk adenomas
Systematic review with meta-analysis: meat consumption and the risk of hepatocellular carcinoma
Systematic review: the management of chronic diarrhoea due to bile acid malabsorption
The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active ulcerative colitis
Adjunct antibiotic combination therapy for steroid-refractory or -dependent ulcerative colitis: an open-label multicentre study
The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients
Long-term prognosis of clinical symptoms and health-related quality of life in microscopic colitis: a case–control study
Evaluating the functional net value of pharmacologic agents in treating irritable bowel syndrome
Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients
Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients
Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients – authors' reply
Commentary: independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer
Commentary: independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer – authors' reply
Letter: apoptosis and hepatic fibrosis in chronic hepatitis B
Letter: apoptosis and hepatic fibrosis in chronic hepatitis B – authors' reply
Letter: gender-associated cell-free microRNA profiles in non-alcoholic fatty liver disease
Letter: gender-associated cell-free microRNA profiles in non-alcoholic fatty liver disease – authors' reply
Letter: probiotics vs. lactulose for minimal hepatic encephalopathy therapy
Letter: probiotics vs. lactulose for minimal hepatic encephalopathy therapy – authors' reply
Letter: low risk of colorectal cancer in a Greek cohort of inflammatory bowel disease patients